Clinical Trial Update: Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Completed Phase 3 long-term study evaluating WelChol as add-on therapy for patients with Type 2 diabetes, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED